NICE issues draft guidance on dependence-forming medicines

NICE issues draft guidance on dependence-forming medicines  

The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...
CHASE updates its services and increases its divisions

CHASE updates its services and increases its divisions

CHASE, the UK’s largest independent provider of contract customer-facing teams, has carried out a programme of industry and NHS market research, to better understand...
Ground-breaking AI test could transform breast cancer diagnosis and treatment

Ground-breaking AI test could transform breast cancer diagnosis and treatment

Panakeia’s PANProfiler Breast assay - the world’s first AI software that can predict biomarker status from digitally imaged routine pathology samples - has received...
NHS Confederation calls for more measures to avoid a winter crisis

NHS Confederation calls for more measures to avoid a winter crisis

The NHS Confederation is calling for a ‘Plan B plus’ in a plea for the government to introduce measures, such as mandatory face coverings...
Star OUTiCO achieves Platinum Investors In People accreditation

Star OUTiCO achieves Platinum Investors In People accreditation

Star OUTiCO, a market-leading provider of outsourced digitally enabled commercial services to the pharmaceutical industry, and part of the global Uniphar Group, has announced...
NICE issues draft recommendation for Forxiga to treat kidney disease

NICE recommends Ofev for the treatment of PF-ILD

The National Institute for Health and Care Excellence (NICE) has recommended Ofev® (nintedanib) for use in England and Wales for the treatment of adult patients...
NICE recommends new treatment for asthma in the UK

NICE recommends new treatment for asthma in the UK

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending Dupixent® (dupilumab), as an add-on maintenance treatment...
New study to explore if talazoparib could treat metastatic breast cancer

New study to explore if talazoparib could treat metastatic breast cancer

A new study funded by Breast Cancer Now will explore if the drug talazoparib (Talzenna) could be used to treat people with incurable secondary...
£250 million winter access fund for GPs to boost face to face appointments  

£250m winter access fund for GPs to boost face to face appointments  

The NHS has published a blueprint for improving access to GP appointments for patients alongside supporting GPs and their teams. Surgeries will be provided with additional funding...
Positive SMC decision for first long-acting injectable HIV treatment

Positive SMC decision for first long-acting injectable HIV treatment

ViiV Healthcare has announced that the Scottish Medicines Consortium (SMC) has accepted Vocabria▼ (cabotegravir long-acting injection) in combination with Rekambys▼ (rilpivirine long-acting injection) for...

Latest articles

NICE recommends Tagrisso for patients with early-stage lung cancer

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy

EC grants marketing authorisation for breast cancer treatment Trodelvy

The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NICE recommends Tagrisso for patients with early-stage lung cancer

NICE recommends Tagrisso for patients with early-stage lung cancer

Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
pharmafield logo - pharma news

A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT

What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
JCVI responds to Omicron variant and updates its guidance

JCVI responds to Omicron variant and updates its guidance

The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
Image of a number of blocks and levels with different icons including magnifying glass, target, steps and graphs to show Coronavirus clinical research brought together in free information centre

Understanding the role of the MSL

Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription